USD 4.4 billion
Intrauterine Contraceptive Devices Market Size, Share, and Growth Analysis
Intrauterine Contraceptive Devices Market By Type (Hormonal Intrauterine Device, Copper Intrauterine Device), By Product Type (Mirena, Skyla), By Age Group, By End Use, By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35A3009 |
Region:
Global |
Published Date: May, 2025
Pages:
195
|Tables:
121
|Figures:
72
Format -
Intrauterine Contraceptive Devices Market Insights
Global Intrauterine Contraceptive Devices Market size was valued at USD 4.4 billion in 2023 and is poised to grow from USD 4.6 billion in 2024 to USD 6.6 billion by 2032, growing at a CAGR of 4.6% during the forecast period (2025-2032).
The Intrauterine Contraceptive Devices (IUDs) market has expanded immensely over the last decade as a result of increased awareness of family planning and reproductive health. IUDs are among the most effective and longest-standing methods of contraception, and growing popularity for effectiveness and low maintenance requirements. IUDs placed in the uterus offer extended protection against pregnancy without the requirement of daily intervention. IUDs have emerged as an economic and risk-free option, resulting in increased usage by women of all segments. Increased emphasis on maternal health and the impetus provided by the government in the area of family planning are some of the key market growth drivers. Increased demand for convenience-based and hormone-free contraceptives will make the IUD market larger. The technology improvement, with the presence of new products centered on ease of use, has boosted the need for IUDs. Multiple drivers are behind the growth in the IUD market.
There is increased birth planning and control awareness, one of the driving forces. Governments, NGOs, and health organizations have helped promote awareness among individuals about the existence and benefits of IUDs. Further, intense demand for long-term birth control and increasing participation of women in the labor market have boosted expansion. IUDs provide women with the privilege of being secure without doing anything else in terms of a day-to-day activity and therefore are a preference for busy individuals. Market growth has also been triggered by the development of non-hormonal IUDs, which have been in high demand among women who want alternatives to hormonal products that may cause side effects. Faster growth in emerging economies because of increased emphasis on reproductive health has also opened new avenues for growth. With more women in developing countries having access to healthcare services, the use of IUDs will also increase, thereby propelling the market further. There are numerous advantages of IUDs with some limitations to market growth.
The primary limitations are cultural and social taboo regarding contraceptive products in some regions. In some communities, resistance in the adoption of IUDs has been seen because of myths based on safety and side effects, hence hindering adoption. Furthermore, the invasive nature of IUD insertion, although less hazardous, is avoided by some women who prefer to adopt other methods. The process is painful, uncomfortable, or may result in complications such as infection that would discourage one from adopting IUDs. Also, the cost of IUDs and insertion may be extremely high in poor areas and therefore cannot be reached by everyone. Although there are challenges within the healthcare sector that fight such challenges, there are still economic and cultural hurdles. In addition, the fact that other contraceptive types like oral contraceptives and condoms are available that are deemed less invasive and easily accessible poses a competition for IUDs' market since such restricts its growth potential within some niches.
How is Artificial Intelligence is revolutionizing the Intrauterine Contraceptive Devices (IUD)?
Artificial Intelligence (AI) is transforming the Intrauterine Contraceptive Devices (IUD) market into making the process more personalized and convenient. AI-powered systems analyze individual health information—i.e., medical history, hormone levels, and lifestyle—and suggest the most appropriate type of IUD, whether hormonal or non-hormonal. The tailored model addresses the various needs of women, providing the maximum level of contraceptive effectiveness with the lowest level of side effects. AI is also making virtual health assistants and online consultations possible and thereby reproductive healthcare more accessible, particularly among marginalized populations. AI is thus not only enhancing the precision of contraceptive decisions but also ensuring equal access to reproductive health care. For example,
The greatest achievement is the development of AI-based genetic testing websites, like Pexxi, which enable women to choose the best hormonal contraceptive based on their individual hormonal and genetic profile. The strategy is to reduce the trial-and-error process in searching for a birth control capable of reducing adverse effects.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
Mirena
Fastest Growth
Mirena
Growth Rate
4.6% CAGR
Global Intrauterine Contraceptive Devices Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Intrauterine Contraceptive Devices Market Segments Analysis
The Global Intrauterine Contraceptive Devices Market is segmented by Type, Product Type, Age Group, End Use and region. Based on Type, the market is segmented into Hormonal Intrauterine Device and Copper Intrauterine Device. Based on Product Type, the market is segmented into Mirena, Skyla, Paragard, Essure, Levosert and Others. Based on Age Group, the market is segmented into 15-24 years, 25-34 years, 35-44 years and Above 44 years. Based on End Use, the market is segmented into Hospitals, Gynecology Clinics, Community Health Care Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
How are Mirena Promoting the Use of Intrauterine Contraceptive Devices?
According to the 2024 global market report of Intrauterine Contraceptive Devices, Mirena led the market with the largest market share obtained. Its rate of growth is mainly due to its twin advantage of contraception and therapeutic use, i.e., for the treatment of heavy menstrual bleeding. Mirena's five-year success and the fact that it emits a hormone have made the old mode of birth control obsolete. Mirena increased in 2024, particularly among older healthcare markets where LARC is overwhelmingly in demand. Patient and physician dollars are saved with Mirena, tallying millions of US dollars by avoiding frequent repeat contraceptive procedures.
- In Feb 2024, Bayer has released new guidelines on the use of Mirena, encompassing its application among women who require long-term contraception use for a maximum period of seven years, further solidifying market leadership for Mirena. In the meantime, Skyla is expanding at a sustainable CAGR of 11.2%.
Skyla has been drawing nulliparous, younger women looking to take lower doses of hormones and smaller devices based on multiple clinical trials. The healthcare marketplace for birth control seems to be moving towards smaller, tailored solutions in an effort to address the needs of individualized patients and minimize side effects.
How do SMEs (small healthcare providers) benefit from using Skyla in terms of cost reduction?
Small and Medium Size Businesses (SMEs) like small community clinics and private gynecological clinics gain a lot through advocating for Skyla, mainly through lower-cost patient management and enhanced patient retention. There were an estimated 358 million SMEs in 2023 in the whole world, and most of them have limited healthcare resources. They enable such clinics to deliver high-quality, low-intervention contraceptive services with little follow-up processes like Skyla, having a three-year action and low incidence of insertion-related issues.
This short- and long-term protection model decreases operation cost and patient follow-up visits. Large hospital chains are the second-largest and largest growing sub-segment of the Global Intrauterine Contraceptive Devices Market following requests for scalable, evidence-based family planning services. Large health institutions are quickly embracing products such as Skyla and Mirena into extended women's health programs that allow for more individualized, effective reproductive health care delivery.
Global Intrauterine Contraceptive Devices Market Analysis by Product Type
To get detailed analysis on other segments, Request For Free Sample Report
Intrauterine Contraceptive Devices Market Regional Insights
What makes North America the top market for Intrauterine Contraceptive Devices in 2024?
North America dominates the worldwide intrauterine contraceptive devices (IUD) market based on enormous healthcare spends, universal insurance coverages, and continuous government promotion of family planning modes. Geographical focus on solutions to long-acting reversible contraception (LARC) and increased product technology advances for IUD have also benefited the growth process. Access by the leading participants and highly sophisticated existing healthcare systems are another benefit of the region. On top of that, a rise in awareness campaigns and educational programs has increased the popularity and use of IUDs among women, and North America emerged as a global market leader for the second time.
The United States Intrauterine Contraceptive Devices Market
The United States intrauterine devices market reached a revenue of USD 1,560.7 million in 2023 and is anticipated to grow to USD 2,183.4 million by 2030 at a CAGR of 4.9% from 2024-2030. The growth is driven by the widespread usage of hormonal IUDs, which accounted for the leading revenue-generating product segment in 2023. The United States held 25.0% of the world intrauterine devices market in 2023, its gigantic contribution to the world.
Canada Intrauterine Contraceptive Devices Market
Canada will be the fastest-growing country in the North American intrauterine devices market between 2024-2030. Market growth in Canada is driven by increasing awareness about IUDs, favorable government policies, and universal healthcare coverage of IUDs. Between 2023, Canada had USD 88.3 million government funding for bilateral family planning, which reflects the country's focus on reproductive health programs.
How are Government Policies in the Asia-Pacific Driving the Growth of the Intrauterine Contraceptive Devices Market?
Asia Pacific will be the growth-driven intrauterine contraceptive devices market region, led by a fast-growing population, rising demand for effective contraception, and changing healthcare infrastructure. Government initiatives on family planning and women's health, rising awareness and acceptance of new contraceptive technologies, are fueling the market growth. Women empowerment, urbanization, and lifestyle changes in the region also drive the rising use of IUDs.
Japan Intrauterine Contraceptive Devices Market
Japan's IUD market is recording growth due to advances in technology coupled with increased need for long-acting reversible contraceptives. Japan's population aging as well as its declining birth rate has driven government interest in reproductive health and increased the demand for effective means of contraception such as IUDs. Moreover, partnership among healthcare professionals as well as governments tries to increase access and enhance information on the utilization of IUDs among women.
South Korea Intrauterine Contraceptive Devices Market
South Korea is experiencing growth in the use of IUDs fueled by government-sponsored family planning programs and public awareness of contraceptive devices. Focus on the reproductive health and rights of women in South Korea has also spurred the inclusion of IUDs in South Korea's national health programs. Education interventions and activities supplementing healthcare providers are expanding the acceptability and accessibility of IUDs among South Korean women.
How is Europe Maintaining Its Position in Intrauterine Contraceptive Devices Market?
Europe holds a significant share of the world's intrauterine contraceptive devices market due to higher usage and demand for IUDs, well-developed health infrastructures, and efficient government policies concerning family planning and women's health. Proper emphasis by the region on long-acting reversible contraception, higher awareness about the advantages of IUDs, and pregnancy postponement trend drive the market growth.
Germany Intrauterine Contraceptive Devices Market
Germany is forecasted to dominate the European intrauterine contraceptive devices market over 2025-2033. Its market growth is being fueled by government efforts, increasing technological progress, and a high abortion rate in the nation, reflecting the necessity of effective contraception strategies. Such technologies as the fertility-sparing intrauterine device, Womed Leaf, with a CE mark in September 2021, are fueling the German IUD market growth.
UK Intrauterine Contraceptive Devices Market
The United Kingdom is expected to have the second-largest market share in the European intrauterine contraceptive devices market. The growth of the country's market is driven by new medical device launches, government initiatives for family planning, and a high rate of IUD usage. The UK emphasis on access to women's reproductive health and services also encourages the use of IUDs.
Global Intrauterine Contraceptive Devices Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Intrauterine Contraceptive Devices Market Dynamics
Intrauterine Contraceptive Devices Market Drivers
Rising Demand for Long-Acting Reversible Contraception (LARC).
- Increasing uptake of long-acting reversible forms of contraception, including intrauterine contraceptive devices (IUDs), is one of the key market drivers. Women are increasingly opting for methods that are effective, low maintenance, and long-acting in preventing pregnancy. IUDs are over 99% effective and have a duration of 3–10 years, depending on the type, and hence provide a convenient option to short-term or daily contraceptives. Secondly, healthcare professionals actively prescribe LARC methods as a first-line contraceptive method and hence propel the use of IUDs. Awareness campaigns regarding the convenience and reliability of LARCs are leading to greater acceptability among various demographic and geographical segments.
Government Initiatives and Family Planning Programs
- Government reproductive health and family planning policies and programs are significant contributors to the intrauterine contraceptive devices market. Public health initiatives, especially in developing economies, focus on providing cost-efficient and effective means of contraception such as IUDs. USAID and WHO also engage in awareness campaigns and subsidized dispensation of IUDs among lower-income segments. Mass family planning drives in India, Brazil, and China have promoted intrauterine device usage enormously. They are also very essential in avoiding unwanted pregnancies as well as improving the overall health of women.
Intrauterine Contraceptive Devices Market Restraints
Cultural and Social Barriers to Adoption
- Even medically valuable, intrauterine contraceptive device adoption is avoided in most places for cultural and social reasons. Misinformation on IUD safety, effect on fertility, and discomfort during procedures persists in the Asian, African, and Middle East regions. In most societies, contraception is a taboo subject, and women cannot access effective birth control techniques such as IUDs without restriction. Moreover, rumor about severe side effects or religious objections is another reason for the barrier to market penetration. All these sociocultural factors have to be addressed by special education campaigns and community-based campaigns in order to enhance information and acceptability of IUDs among ambivalent segments.
Risk of Complications and Side Effects
- Clinical intrauterine device risks are a significant market growth barrier. Although low, possible risks such as uterine perforation, infection, expulsion, and excessive bleeding discourage women from using IUDs. The risk of invasive treatment and fear of being uncomfortable when inserting or having one removed also discourage use. Additionally, negative effects of cramping, spotting between menses, or hormonal imbalance (in case of hormonal IUDs) cause withdrawal. The professionals usually have to invest extra time counseling patients regarding benefits and risks, and this may slow down overall adoption rates among certain patient groups.
Request Free Customization of this report to help us to meet your business objectives.
Intrauterine Contraceptive Devices Market Competitive Landscape
The market for intrauterine contraceptive devices (IUD) is highly competitive with established vendors and new-generation companies. Bayer AG possesses the largest market share of approximately 35% because of its differentiated hormonal IUD portfolio, i.e., Mirena, Skyla, and Kyleena, which cater to different patient segments. Merck & Co. possesses the second with approximately 25% market share because of its strong business in hormonal and copper IUD markets, especially in emerging markets. Firms are emphasizing product innovation, i.e., concentrating on the development of small, flexible IUDs for nulliparous women and growing in emerging markets in strategic alliances and public education campaigns.
- Medicine360: Founded in 2009, this not-for-profit pharma seeks to increase access to women's health. LILETTA, its lead product, is a hormone-releasing intrauterine device for 8 years of contraceptive use and treatment of heavy menstrual bleeding for up to 5 years. By selling it at a lower price through the 340B drug discount program, LILETTA allows Medicines360 to advance its goal of making contraception more affordable.
Top Player’s Company Profiles
- Teva Pharmaceutical Industries Ltd. (Jerusalem)
- Bayer (Germany)
- EUROGINE (Spain)
- CooperSurgical Inc. (US)
- Pfizer Inc. (US)
- HLL Lifecare Limited (Thiruvananthapuram)
- OCON Medical Ltd. (Israel)
- Prosan International BV (Netherlands)
- Melbea Innovations (Hungary)
- Allergan, Merck & Co., Inc. (US)
- DKT International (US)
- Medisafe Distribution Inc. (Canada)
- Medicines360 (US)
- Pregna International Limited (India)
- Egemen International (Turkey)
Recent Developments in Intrauterine Contraceptive Devices
- Medicines360 made strategic alliances with DKT WomanCare in January 2024 to introduce the hormonal IUD Avibela™ into additional markets with increased access. The alliance is geared toward increasing access to contraception at low price in less-resourceful markets in line with Medicines360's vision to empower women's health worldwide. The alliance will drive distribution networks and support public health programs for reproductive and family health.
- In 2024, OCON Healthcare made public the release of positive long-term efficacy and safety findings for its non-hormonal IUB Ballerine contraceptive. Findings, based on more than 100,000 users, showed high satisfaction and low complication rates, affirming the device's reputation as a trusted non-hormonal contraceptive. The release is consistent with OCON's mission to deliver innovative and effective reproductive healthcare solutions.
- Bayer has invested more than €400 million in 2024 to expand access to modern contraception. The company will establish a cutting-edge production site in Costa Rica manufacturing long-acting reversible contraceptives (LARCs), such as hormonal IUDs. The site will be used to supply LARCs to low- and middle-income countries in line with Bayer's ambition to reach 100 million women and girls with access to family planning by the year 2030.
Intrauterine Contraceptive Devices Key Market Trends
- Increasing Demand for Non-Hormonal Contraceptives: The demand for non-hormonal intrauterine contraceptive devices is increasing rapidly as more women opt for hormone-free options. Devices such as the Copper IUD are becoming popular due to their long-term nature but non-interference with hormonal balances. This trend is especially strong in those markets with consumers who are health-conscious and choose non-invasive, hormone-free products to escape side effects of hormonal birth control. The market is reacting to the need for more comfort and design in non-hormonal IUDs to meet this increasing demand, and they are now a competitive product on global markets.
- Technological Advancements in IUD Design.: Advances in technology are transforming intrauterine device (IUD) designs, making the user more comfortable, effective, and simpler to insert. For example, the IUB™ Ballerine® is a cushy, spherical design that eliminates pain and expulsion rates. All of these advancements aim to counteract traditional IUD failures like pain and user acceptability. Companies are investing in R&D for the creation of smaller and more diverse devices, and innovative material application to further extend safety and convenience and thus popularize IUDs among more women worldwide. Intrauterine contraceptive device (IUD) market is being driven by increasing demand for long-acting reversible contraception (LARC) technology.
Intrauterine Contraceptive Devices Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected using Primary Exploratory Research backed by robust Secondary Desk research.
SkyQuest’s study suggests that IUDs are more strongly preferred by women due to the fact that they work well, are simple to maintain, and are long-lasting. Social and cultural barriers remain a challenge, especially in areas where contraception is poorly understood or discouraged. The North American market leads globally with the largest market share because they have good health systems, extensive insurance coverage, and government support for family planning interventions. With leadership in adoption and revenue in the market being hormonal IUD. Further, government-funded family planning programs will continue to lead the market by growth, particularly in developing countries.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 4.4 billion |
| Market size value in 2032 | USD 6.6 billion |
| Growth Rate | 4.6% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Intrauterine Contraceptive Devices Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Intrauterine Contraceptive Devices Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Intrauterine Contraceptive Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Intrauterine Contraceptive Devices Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Intrauterine Contraceptive Devices Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Intrauterine Contraceptive Devices Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Intrauterine Contraceptive Devices Market Report Snapshots
REQUEST FOR SAMPLE
Want to customize this report?
REQUEST FREE CUSTOMIZATION
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
